Target intelligence / Profile preview

CTBP2 pseudogene 3 (CTBP2P3)

Target
CTBP2P3
Molecular classification
Other (pseudogene)
01

Overview

CTBP2 pseudogene 3 (CTBP2P3) is a non-protein-coding gene annotated in the human genome as a pseudogene homolog of the CTBP2 locus, which encodes the transcriptional regulator C-terminal binding protein 2. Unlike the functional CTBP2, which participates in chromatin remodeling, gene expression regulation, and is implicated in cancer biology and inflammation[2][3][4], CTBP2P3 does not encode an active protein. Pseudogenes such as CTBP2P3 are typically regarded as remnants of gene duplication or retrotransposition events, lacking proven biological function or direct relevance as therapeutic targets. Summary of issues: The query appears to conflate CTBP2P3 with CTBP2, a well-studied transcriptional co-repressor and cancer target[2][3][4]. CTBP2P3 is not a receptor, enzyme, transporter, transcription factor, or any functional molecule, nor does it serve as a biomarker or drug target. Information relevant to therapeutic targeting, drug interactions, or disease association applies only to CTBP2 itself. If detailed structured information about C-terminal binding protein 2 (CTBP2) is required instead, this should be clarified, as CTBP2 is an active transcriptional regulator implicated in oncogenesis and inflammation[2][3]. Otherwise, for CTBP2P3, the appropriate structured data reflects its status as a pseudogene without known functional or therapeutic relevance.

Other names
CTBP2P3CTBP2-pseudogene 3

Beyond the preview

Go deeper on CTBP2 pseudogene 3 (CTBP2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTBP2 pseudogene 3 (CTBP2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call